What are the best treatments for Ledderhoses Disease / Plantar Fibromatosis?

TL;DR: Treatment for Ledderhoses disease (plantar fibromatosis) focuses on symptom management and pain reduction, as there is currently no cure to reverse the formation of fibromas. First-line approaches typically include non-surgical methods like orthotics, physical therapy, and corticosteroid injections, while surgery is generally reserved for cases involving significant pain or functional impairment due to the high risk of recurrence.

What are the first-line treatments for Ledderhoses disease?

The primary goal when managing Ledderhoses disease is to maintain mobility and minimize discomfort. Because the condition involves the growth of benign nodules in the plantar fascia, clinicians often start with conservative, non-invasive therapies. Patients are frequently advised to use custom-molded orthotics or shoe inserts to offload pressure from the fibromas. Physical therapy, including gentle stretching and massage, may help manage tension, although it will not shrink the established nodules. For acute pain, corticosteroid injections (such as triamcinolone) are sometimes used to reduce local inflammation, though results vary significantly between individuals.

What medications and non-pharmacological interventions are available?

While no medication currently cures Ledderhoses disease, several options are utilized to manage the impact of the condition. Treatment protocols often include the following:

• Corticosteroid Injections: Used to manage inflammation and pain, though they do not resolve the fibrous tissue.


• Orthotics: Custom shoe inserts designed to redistribute weight away from the nodules.


• Radiation Therapy: Low-dose external beam radiation is sometimes considered in stubborn cases to arrest the growth of the fibromas.


• Collagenase injections: While more common for Dupuytren’s contracture (a related condition), some providers explore this off-label for Ledderhoses disease.


• Surgical Excision: Often a last resort due to a high recurrence rate (which can exceed 50% in some clinical reports) and the potential for developing painful scarring or flat-foot deformities.

What is the multidisciplinary approach to managing Ledderhoses disease?

Because Ledderhoses disease can affect gait and daily quality of life, a coordinated care team is essential. We recommend that patients build a team consisting of a podiatrist or orthopedic surgeon specializing in foot and ankle conditions, a physical therapist with experience in connective tissue disorders, and a pain management specialist if symptoms become chronic. At DiseaseMaps.org, 95 community members have shared their experiences, highlighting that what works for one person may not be effective for another, underscoring the need for a personalized, trial-and-error approach under expert guidance.

Are there emerging treatments for Ledderhoses disease?

Research into Ledderhoses disease is ongoing, with investigators exploring non-surgical interventions that might stabilize or shrink nodules. Current clinical literature discusses the potential of verapamil gel—a calcium channel blocker—which has shown mixed results in reducing nodule size in some patients. Because the condition is rare, large-scale clinical trials are limited, and most "emerging" treatments are currently based on small cohort studies or data extrapolated from related fibromatoses like Dupuytren’s contracture.

Next steps

• Consult a board-certified podiatrist or orthopedic foot and ankle surgeon to confirm the diagnosis and rule out other causes of foot pain.


• Keep a symptom diary to track how your Ledderhoses disease nodules respond to different footwear and activity levels.


• Join the DiseaseMaps.org community to connect with other patients and share experiences regarding treatment outcomes.


• Ask your physician about the risks and benefits of specific interventions before proceeding with invasive procedures.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional to determine the best treatment plan for your specific clinical needs.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Plantar Fibromatosis.


• Orphanet: Ledderhose disease (ORPHA:99925).


• OMIM (Online Mendelian Inheritance in Man): Plantar Fibromatosis (#126900).


• PubMed: Current clinical literature on the management of Ledderhoses disease and outcomes of surgical vs. non-surgical intervention.